ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis
April 23, 2021Lipidor AB (publ) provides an update on the planned Phase III study of the company's drug candidate AKP02 for the treatment of psoriasis. During the first quarter of 2021, Lipidor submitted an application to the Indian Medical Products Agency for ... -
Lipidor announces positive outcome of feasibility study for development of topical medical cannabis products based on the company's AKVANO® technology
October 09, 2020Lipidor AB today announces a positive outcome of the feasibility study into the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions.
Pharma Sources Insight January 2025
